[518] Expression of CD10 and MMP-11 in the Differential Diagnosis of Dermatofibroma Variants and Dermatofibrosarcoma Protuberans
Changqing Ma, Smita Krishnamurthy, Louis P Dehner, Dongsi Lu. Washington University in St. Louis, St. Louis, MO
Background: Dermatofibrosarcoma protuberans (DFSP) is a fibrohistiocytic tumor of intermediate malignancy and carries significant risk of local recurrence. The distinction between DFSP and dermatofibroma (DF), especially its variants (VDF), can be challenging. CD10 and MMP-11 were found to be useful markers for the differential diagnosis of classical DF and DFSP. We sought to characterize the staining patterns of CD10 and MMP-11 in a large set of VDF and study the utility of these two stains in differential diagnosis of VDF and DFSP.
Design: Immunohistochemical (IHC) stains were performed on 31 cases of DFSP, 38 cases of DF, and 41 cases of VDF using antibodies to CD34, Ki67, CD10, and MMP-11. Of 41 VDF cases, 18 were aneurismal type, 16 lipidized type, 4 with both aneurismal and lipidized features, 1 cellular type, 1 with monster cells, and 1 atypical fibrous histiocytoma.
Results: Thirty-six of 41 (88%) VDF cases and 37 of 38 (97%) DF cases were CD34 negative but only 2 of 31 (6%) DFSP cases showed no staining of CD34. All DFSP cases were positive for Ki67 and 22 of 31 (71%) cases had positive Ki67 stain in 5% or more tumor cells. Comparable staining patterns were observed in 5 of 41 (12%) VDF cases and 1 of 38 (3%) DF cases. CD10 and MMP-11 staining results were shown in Table 1.
| CD10 | MMP-11 | |||||
|---|---|---|---|---|---|---|
| IHC results (% of tumor cells positive) | DF (38) | VDF (41) | DFSP (31) | DF (38) | VDF (41) | DFSP (31) |
| 0% | 2.6% (1) | 0% (0) | 9.7% (3) | 0% (0) | 0% (0) | 77.4% (24) |
| 1 - 10% | 0% (0) | 0% (0) | 29.0% (9) | 2.6% (1) | 34.2% (14) | 16.1% (5) |
| 10 - 25% | 10.5% (4) | 7.3% (3) | 22.6% (7) | 2.6% (1) | 7.3% (3) | 6.5% (2) |
| 25 - 50% | 23.7% (9) | 17.1% (7) | 19.4% (6) | 10.5% (4) | 26.8% (11) | 0% (0) |
| 51- 75% | 36.8% (14) | 41.5% (17) | 12.9% (4) | 31.6% (12) | 12.2% (5) | 0% (0) |
| 76 -100% | 23.7% (9) | 34.1% (14) | 0% (0) | 50.0% (19) | 19.5% (8) | 0% (0) |
| Other* | 2.6% (1) | 0% (0) | 6.4% (2) | 2.6% (1) | 0% (0) | 0% (0) |